← Back to Clinical Trials
Recruiting NCT06726083

NCT06726083 Improving Dietary Quality and Social Engagement Through a Virtual Nutrition and Teaching Kitchen Intervention Among Older Veterans With Impaired Mobility

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06726083
Status Recruiting
Phase
Sponsor VA Office of Research and Development
Condition Impaired Mobility
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2026-03-31
Primary Completion 2030-03-31

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Nutrition InterventionContact Control

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 180 participants in total. It began in 2026-03-31 with a primary completion date of 2030-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Compared to non-Veterans, Veterans demonstrate an increased risk for obesity and multimorbidity. Thus, interventions to improve overall health are warranted in this population. Healthy diets that include fruits and vegetables are linked to a reduced risk of chronic disease including mobility disability, and are associated with higher muscle mass, strength and physical performance potentially slowing further disability progression later in life. The investigators will determine if a three-month virtual group nutrition intervention paired with produce delivery and virtual teaching kitchen cooking demonstrations tailored for older Veterans with impaired mobility will improve diet, health-related quality of life and muscle strength.

Eligibility Criteria

Inclusion Criteria: * Veterans \>65 years with reduced gait speed (gait speed \<1.0 m/s) or elevated four square step test * use of an assistive device who also indicate that they would like to improve their eating habits, defined by response of \<3 on a scale of 1 to 5 to the question, 'Do you consider your eating habits to be healthy' Exclusion Criteria: * Uncontrolled diabetes mellitus (HbA1c \>10) or Current renal replacement therapy (e.g. dialysis) * Other medical condition precluding patient participation in this study as per medical judgment of study team * dementia as self-reported or found on medical record review * currently participating in a diet or weight loss intervention * Volatile behavior issues or unable to work successfully in a group environment/setting

Contact & Investigator

Central Contact

Jeffrey P Beans, BS

✉ jeffrey.beans@va.gov

📞 (410) 605-7000

Principal Investigator

Elizabeth A Parker, PhD RD

PRINCIPAL INVESTIGATOR

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Frequently Asked Questions

Who can join the NCT06726083 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Impaired Mobility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06726083 currently recruiting?

Yes, NCT06726083 is actively recruiting participants. Contact the research team at jeffrey.beans@va.gov for enrollment information.

Where is the NCT06726083 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT06726083 clinical trial?

NCT06726083 is sponsored by VA Office of Research and Development. The principal investigator is Elizabeth A Parker, PhD RD at Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD. The trial plans to enroll 180 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology